mit Professor Dr. Sven Hammerschmidt und Professor Dr. Nikolai Siemens (beide Universität Greifswald, Abteilung Molekulare Genetik und Infektionsbiologie, Interfakultäres Institut für Genetik und Funktionelle Genomforschung)

Streptococcal species include commensals, but also pathobionts like pneumococci and group A streptococci (GAS). Despite available (conjugate-)vaccines, pneumococci are the leading cause of morbidity and mortality in children and older adults. However, vaccine coverage among serotypes is low, the vaccine is expensive and antimicrobial resistance is increasing. Thus, new protein-based serotype-independent vaccines or intervention strategies are needed. While pneumococci cause pneumonia, sepsis and meningitis, GAS diseases range from uncomplicated throat infections to severe invasive infections, such as necrotizing fasciitis. No vaccine is available against GAS. This presentation will highlight structure-function analysis as well as protectivity of putative pneumococcal vaccine candidates and GAS heterogeneity in severe infections.

Sven Hammerschmidt is the Head of the Department Molecular Genetics and Infection Biology, University of Greifswald. After completing his doctorate in Microbiology in 1996 (Hannover), he started his postdoctoral studies on Streptococcus pneumoniae virulence factors at the Helmholtz Center for Infection Research (1996-2003). After moving his group to the Research Center for Infectious Diseases at the University of Würzburg (2023-2007), he became Professor (W2) at the Institute for Medical Microbiology, LMU Munich in 2007. In 1998, he received the Robert Koch Award for Post-Docs and in 2007 the Becton-Dickinson Research Award for his studies on the host-pathogen interplay of the pathobiont S. pneumoniae.

Nikolai Siemens is associate professor at the Department of Molecular Genetics and Infection Biology, University of Greifswald. He received his diploma and doctoral degrees from the University of Rostock in 2009 and 2012, respectively. In 2016, he completed postdoctoral studies on necrotizing skin and soft tissue infections at the Center for Infectious Medicine, Karolinska Institutet (Stockholm, Sweden). In 2017, Nikolai Siemens established his research group at the University of Greifswald. His team has an interest in host-pathogen interactions and the work currently performed investigates the impact of host environment on different streptococci and vice versa.

Moderation: Professor Dr. Thomas Klinger